Trials / Completed
CompletedNCT06087588
Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis
The Impact of the Pericapsular Nerve Group Block (PENG) Chemical Neurolysis on the Quality of Life of Patients with Advanced Hip Osteoarthritis. a Randomized, Prospective Double-blinded Clinical Trial.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Poznan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
PENG neurolysis in advanced osteoarthritis of the hip joint.
Detailed description
The study aims to assess the safety and effectiveness of regional pain treatment methods and their impact on the quality of life of patients with advanced osteoarthritis of the hip joint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.9%sodium chloride | PENG sham block with 20ml 0,9% normal saline |
| DRUG | 95% ethanol | PENG neurolysis with 2.5ml of 95% ethanol |
Timeline
- Start date
- 2023-10-17
- Primary completion
- 2025-01-10
- Completion
- 2025-01-14
- First posted
- 2023-10-18
- Last updated
- 2025-01-21
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06087588. Inclusion in this directory is not an endorsement.